Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | LAP3 | P28838 | 2/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CETP | P11597 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | UBE2N | P61088 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23358953 | 1.00 | OPRM1 (0.50) | OPRM1SPHK1CYP2D6LMNATP53 | |
| SCHEMBL23358986 | 1.00 | OPRM1 (0.50) | OPRM1SPHK1CYP2D6LMNATP53 | |
| SCHEMBL23359008 | 1.00 | OPRM1 (0.50) | OPRM1SPHK1CYP2D6LMNATP53 | |
| SCHEMBL23358928 | 1.00 | OPRM1 (0.50) | OPRM1SPHK1CYP2D6LMNATP53 | |
| SCHEMBL3678135 | 0.97 | OPRM1 (0.52) | OPRM1SPHK1CYP2D6LMNATP53 | |
| SCHEMBL3676611 | 0.90 | OPRM1 (0.42) | OPRM1SPHK1CYP2D6LMNATP53 | |
| SCHEMBL6060496 | 0.83 | OPRM1 (0.48) | OPRM1SPHK1CYP2D6LMNATP53 | |
| SCHEMBL29153555 | 0.83 | OPRM1 (0.48) | OPRM1SPHK1CYP2D6LMNATP53 | |
| SCHEMBL14663498 | 0.83 | OPRM1 (0.48) | OPRM1SPHK1CYP2D6LMNATP53 | |
| SCHEMBL28372119 | 0.83 | OPRM1 (0.48) | OPRM1SPHK1CYP2D6LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11492710-B2 | Trifunctional amine based corrosion inhibitor compositions | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2022-11-08 | — | — | US | claimed |
| US-20010006976-A1 | Process for preparing azacycloalkanoylaminothiazoles | BRISTOL-MYERS SQUIBB COMPANY | 2001-07-05 | — | — | US | claimed |
| JP-57011018-A | — | — | None | — | — | JP | disclosed |
| JP-7133404-A | — | — | None | — | — | JP | disclosed |
| US-20250043168-A1 | DRILLING FLUID | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2025-02-06 | — | — | US | disclosed |
| CN-116406412-A | Drilling fluid | 奥升德功能材料运营有限公司 | 2023-07-07 | — | — | CN | disclosed |
| US-11492710-B2 | Trifunctional amine based corrosion inhibitor compositions | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2022-11-08 | — | — | US | disclosed |
| US-20220154061-A1 | DRILLING FLUID | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2022-05-19 | — | — | US | disclosed |
| WO-2022103735-A1 | DRILLING FLUID | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2022-05-19 | — | — | WO | disclosed |
| WO-2021101795-A1 | TRIFUNCTIONAL AMINE BASED CORROSION INHIBITOR COMPOSITIONS | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2021-05-27 | — | — | WO | disclosed |
| US-20210147984-A1 | TRIFUNCTIONAL AMINE BASED CORROSION INHIBITOR COMPOSITIONS | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2021-05-20 | — | — | US | disclosed |
| EP-1426392-A1 | COMPOSITION FOR OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-6559314-B2 | Reacting hexamethylenetetramine compound with cysteamine or its salts to produce thiazolidine | PROBIODRUG AG (DE) | 2003-05-06 | — | — | US | disclosed |
| US-6007972-A | Photographic fixing composition containing an oxadiazolethione and method of rapid photographic processing | EASTMAN KODAK COMPANY (US) | 1999-12-28 | — | — | US | disclosed |
| EP-0761404-A1 | Tire curing bladder with improved release characteristics | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1997-03-12 | — | — | EP | disclosed |
| US-5580513-A | CROSSLINKED ELASTOMER; BLEND OF OLEFIN POLYMER AND CORN OIL | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1996-12-03 | — | — | US | disclosed |
| JP-H07133404-A | MOLDING MATERIAL OF PHENOLIC RESIN | TOAGOSEI CO LTD | 1995-05-23 | — | — | JP | disclosed |
| US-5407290-A | Connecting joint for electric furnace electrodes | SOCIETE DES ELECTRODES ET (FR) | 1995-04-18 | — | — | US | disclosed |
| JP-S5711018-A | MANUFACTURE OF PHENOLIC RESIN MOLDING MATERIAL | MATSUSHITA ELECTRIC WORKS LTD | 1982-01-20 | — | — | JP | disclosed |
| EP-0019215-A1 | Process for preparation of denatured polyaddition products from residues of distillation of isocyanates and biomasses and their use as reactive fillers as nutritious matter for plants and as binder in the production of panels or shaped pieces | BAYER AG (DE) | 1980-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010006976-A1 | Process for preparing azacycloalkanoylaminothiazoles | CDK9, CDK4, CDK6 | OPRM1 1735/4885SPHK1 4683/4885CYP2D6 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.